BioCentury
ARTICLE | Clinical News

HyVac4: Phase I started

December 10, 2007 8:00 AM UTC

ICLL began a placebo-controlled, Swedish Phase I trial of HyVac4 in 64 individuals vaccinated with Bacillus of Calmette and Guerin (BCG) vaccine. ICLL is co-developing HyVac4 with Aeras Global TB Vacc...